Dr. Avinash Teli

About

Dr. Avinash Teli was born in Nepal on March 15, 1991; He accomplished his Doctoral in Pharmacy from M.M. College of Pharmacy, MMU, Ambala, India. Dr. Avinash Teli is Head Clinical Pharmacologist and Drug consultant, Department of Clinical Pharmacology, Nayati Medicity, Mathura. Previously, He worked in MMIMSR, Fortis Hospital, Medanta-The Medicity, Eternal Heart care center in Clinical Pharmacology department. He is engaged in Management of Medication Therapy, Prescription validation, Dose calculation, Antibiotic usage, DDD, DRI. Dr. Avinash Teli is Lifetime member of Foundation for Health and Environment Research. Dr.Avinash is Editorial board member in two indexed journal with high impact factor. He is expert in evaluation of the manuscript, quality of the manuscript, He has achieved many certifications from authorities like GCP-NIDA, Pharmacovigilance from UMC, Diabetes prevention from EACCME IDF School of diabetes, Brussels, Belgium. He is trainer for drug information, clinical practice & Safe medication for healthcare team. Dr Avinash has attended several conferences and workshops at national and international levels. He also has presented many posters on international level.

Employment

• Venkateshwar Hospital Dwarka Manager & Head Clinical Pharmacology
  2022 - Present
• Regency healthcare ltd Head Clinical Pharmacology cum AM quality
  2021 - Present
• Nayati Hospital Drug Consultant cum Clinical Pharmacologist
  2019 - 2020
• Eternal Heart Care Center Clinical Pharmacologist
  2018 - 2019
• Medanta The Medicity Clinical Pharmacist
  2017 - 2018
• Maharishi Markandeshwar University Hospital Pharmacist
  2016 - 2017
• Fortis Escorts Heart Institute and Research Centre Clinical Pharmacist
  2016 - 2017

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (6)

• Evaluation and clinical management of drug-drug interactions in hypertensive patients associated co-morbidities: A study in general medicine and ICU ward
  Journal of Pharmaceutical and Biological Sciences 2023 DOI: 10.18231/j.jpbs.2023.010
  +Save
• Vaccine equity and access: A comparative assessment of Covaxin, Covishield, and Sputnik V.
  Indian Journal of Pharmacy and Pharmacology 2023 DOI: 10.18231/j.ijpp.2023.018
  +Save
• Drug use evaluation and rational prescription audit of restricted antibiotics in tertiary care corporate hospital: An interventional study
  IP International Journal of Comprehensive and Advanced Pharmacology 2023 DOI: 10.18231/j.ijcaap.2022.041
  +Save
• A Complete Overview and Guidelines for nCOv-2019 (COVID-19) with Special Reference to Corporate Hospital
  Acta Scientific Microbiology 2020 DOI: 10.31080/asmi.2020.03.0593
  +Save
• A Study of Drug Utilization and Prescribing Patterns of Drugs in Chronic Obstructive Pulmonary Diseased Patients (IPD and OPD) in Tertiary Care Hospital
  Acta Scientific Pharmacology 2020
  +Save
• A PROSPECTIVE STUDY ON DRUG UTILIZATION AND COST EFFECTIVENESS OF TREATMENTS IN DIABETES MELLITUS PATIENTS (INPATIENTS SETTING) IN TEACHING HOSPITAL OF MMIMSR Correspondence
  Journal of Medical Pharmaceutical And Allied Sciences 2019 DOI: 10.13140/RG.2.2.22400.99848
  +Save